NanoDetect
Cross‑border consortium develops nanodiamond‑based relaxometry prototype for earlier, more precise cancer diagnostics.
NanoDetect applies relaxometry using nanoscopic diamonds as optical sensors to identify tumour cells with abnormal metabolism at single‑cell level. The consortium will design and evaluate a prototype resembling an optical microscope, adapted to relaxometry’s specific requirements. The prototype is intended for use in research facilities, clinical laboratories, and potentially hospitals. The project integrates expertise in molecular biology, materials science, optics, electronics, and computer science from Dutch and German partners. Expected outcomes include faster, more precise cancer diagnostics and a foundation for personalised medicine. Lead partner: FH Münster – University of Applied Sciences. Total planned project costs: €5,501,220.48.
Consortium partners:
- German partners: FH Münster – University of Applied Sciences (lead); Universität Osnabrück; IOM Leibniz‑Institut für Oberflächenmodifizierung e.V.; Jüke Systemtechnik GmbH; TAFH Münster GmbH; bill‑X GmbH.
- Dutch partners: Universitair Medisch Centrum Groningen (UMCG); QT Sense B.V. (QTsense).